Neoadjuvant Database

Recruiting

• Conditions: Neoadjuvant Treatment in Breast Cancer
• Interventions: Drug: Neoadjuvant therapy

• Registration Number: NCT04031612
• Lead Sponsor: Centre Georges Francois Leclerc

Brief Summary

The NEOADJ Database base contains data collected during the regular clinical patient management (sociodemographic, clinical, pathological, radiological, biological, disease evolution...). This database allows easy access to information in a centralized and structured way.

This cohort is used to gather insights for research purposes. All data collected come from medical files of patients managed at Centre Georges Francois Leclerc, Dijon, France.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-09-09
• Status Verified: 2019-07
• Study First Submitted: 2019-07-01
• Study First Submitted QC: 2019-07-23
• Last Update Submitted: 2019-07-23
• Study First Posted: 2019-07-24
• Last Update Posted: 2019-07-24
• Primary Completion: 2024-09
• Study Completion: 2024-09

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 2000

Inclusion Criteria

• Women followed for breast cancer in Georges Francois Leclerc Center
• Neoadjuvant chemotherapy
• Age >= 18

Exclusion Criteria

• Males
• Metastatic breast cancer

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Neoadjuvant Breast Cancer	Neoadjuvant therapy	Patients undergoing neoadjuvant therapy for breast cancer

Primary Outcome Measures

Name	Time	Method
Patient survival	5 years	Overall survival and evolution over years

Secondary Outcome Measures

Name	Time	Method
Collection of patient and treatment characteristics	5 years	Collection of patient and treatment characteristics over years, to set up prospective and retrospective studies

Trial Locations

Locations (1)

Methodology, Biostatistics and Data Management Unit; 🇫🇷 Dijon, France